21 research outputs found
Effect Of Baclofen On Liquid And Solid Gastric Emptying In Rats.
Gamma-aminobutyric acid (GABA) is a potent inhibitory neurotransmitter. There is evidence that GABA(B) receptors located in the dorsal complex and in afferent fibers of the vagus nerve participate in the control of gastrointestinal motility. To assess the intracerebroventricularly (ICV) and intravenously (IV) effect of baclofen, a GABA(B) receptor agonist, on liquid and solid gastric emptying in rats. Adult male Wistar rats weighing 250-300 g (n = 6-8 animals) were used. Gastric emptying of liquid test meals labeled with phenol red was evaluated by the determination of percent gastric retention (%GR) 10 and 15 min after orogastric administration of saline and 10% glucose meals, respectively. Baclofen was injected ICV (1 and 2 µg/animal) through a tube implanted into the lateral ventricle of the brain and was injected IV (1 and 2 mg/kg) into a tail vein. The gastric emptying of liquid was determined 10 or 30 min after ICV and IV baclofen administration, respectively. The gastric emptying of the solid meal was assessed by the determination of percent gastric retention 2 h after the beginning of the ingestion of the habitual ratio by the animal, consumed over a period of 30 min. Baclofen was administered ICV (1 and 2 µg/animal) or IV (1 and 2 mg/kg) immediately after the end of the ingestion of the solid meal. The control groups received vehicle (sterile saline solution) ICV or IV. The group of animals receiving baclofen ICV (2 mg/animal) presented a significantly lower (P<0.05, Tukey test) %GR (mean ± SEM) of the saline (18.1 ± 2.5%) compared to control (33.2 ± 2.2%). In the group receiving the drug IV, the gastric retention of the same test meal did not differ from control. ICV and IV administration of baclofen had no effect on the gastric emptying of the 10% glucose solution compared to control. ICV administration of 1 or 2 mg baclofen/animal significantly increased the gastric retention of the solid test meal (57.9 ± 6.5% and 66.6 ± 6.3%, respectively) compared to control (35.1 ± 4.4%). The same phenomenon was observed only with the IV dose of 2 mg/kg (71.9 ± 2.6%) compared to control (52.7 ± 2.8%). Baclofen administered: 1. ICV (2 µg/animal), but not IV, increased gastric emptying of a non-caloric isotonic liquid test meal (saline); 2. when administered ICV or IV, it had no effect of gastric emptying of a 10% glucose solution; 3) when administered ICV (1 and 2 mg/animal) and IV (2 mg/kg) it delayed the gastric emptying of the solid meal.47290-
Effect of an isolated mild to moderate ischemic brain injury in the gastric emptying of liquids in rats
[the Effect Of Bacterial Lipopolysaccharide On The Gastric Emptying Of Rats: A Pretreatment Evaluation Using Dexamethasone And Methylene Blue].
The nitric oxide might be a putative mediator of the decrease in gastric emptying induced by bacterial lipopolysaccharide in rats. For that, we evaluated the effect of the pretreatment intravenous with dexamethasone and methylene blue in the retardation process of gastric emptying induced by intravenous application of lipopolysaccharide in rats. Dexamethasone has been shown to inhibit the induction of NOS II (induced NO-synthase) while the methylene blue, that blocks the soluble guanylyl cyclase, inhibits nitric oxide synthases and, in addition, inactivates nitric oxide directly. Male Wistar rats, specific patogenic free, were used after a 24 hour fast and 1 hour-water withdrawn. The pretreatment was performed using dexamethasone solutions (3 and 6 mg/kg), methylene blue (2 mg/kg) or sterile vehicle. The treatment consisted in the application of lipopolysaccharide (50 mug/kg) or vehicle. The time period between the pretreatment and treatment was 10 minutes, excluding the study with dexamethasone 6 mg/kg that was 1 hour. The gastric emptying was evaluated 1 hour after the lipopolysaccharide application, except for two studies with dexamethasone 3 mg/kg in which the time periods were 2 and 8 hours. A saline solution containing phenol red was used as the test meal. The gastric emptying was determined by measuring gastric retention 10 minutes after the orogastric infusion of the test meal. The pretreatment with dexamethasone or methylene blue and treatment with vehicle did not have effect in the gastric emptying comparing to the control group. We found that pretreatment with dexamethasone in the studies for 1 hour and 2 hours did not interfere in the retardation of the gastric emptying produced by endotoxin. Nevertheless, in the eighth period study with this drug there was a significant reduction of gastric retention in the endotoxin-treated animals in relation to the unpretreated ones. Meanwhile, the pretreatment with the methylene blue completely blocked the action of endotoxin on the gastric emptying in rats. These results suggest a possible involvement of nitric oxide on the effect of lipopolysaccharide in rat gastric emptying.40104-
[the Effect Of Bacterial Lipopolysaccharide On The Gastric Emptying Of Rats: A Pretreatment Evaluation Using Nw-nitro-l-arginine Methyl Ester (l-name)].
There is evidence that nitric oxide plays a role in the decrease in gastric emptying induced by bacterial lipopolysaccharide. To evaluate the effect of pretreatment with Nw-nitro-L-arginine methyl to ester, one competitive inhibitor of the nitric oxide synthases, on the gastric emptying delay induced by lipopolysaccharide. Male Wistar rats, SPF, were used after 24 h fast and 1 h-water withdrawn. The pretreatment was done intravenously with vehicle (saline) or N(w)-nitro-L-arginine methyl to ester in the doses of 0.5, 1, 2.5 e 5 mg/kg. After 10 min, the animals were treated iv with lipopolysaccharide (50 microg/kg) or received vehicle (saline). The gastric emptying was evaluated 1 h after the lipopolysaccharide administration. A saline solution containing phenol red was used as the test meal. The gastric emptying was indirectly assessed by the determination of percent gastric retention of the test meal 10 min after orogastric administration. The animals pretreated with vehicle and treatment with lipopolysaccharide have significant rise of the gastric retention (average = 57%) in comparison with the controls receiving only vehicle (38.1%). The pretreatment with the different doses of N(w)-nitro-L-arginine methyl to ester did not modify per se the gastric retention in comparison with the animals pretreated with vehicle. Pretreatment with N(w)-nitro-L-arginine methyl to ester with the dose of 1 mg/kg determined a discrete but significant reduction in the gastric retention (52%) of animals treated with lipopolysaccharide in comparison with vehicle-pretreated rats. Paradoxically, animals pretreated with 2.5 or 5 mg of N(w)-nitro-L-arginine methyl to ester/kg followed by treatment with lipopolysaccharide displayed a significantly higher gastric retention (74.7% and 80.5%, respectively) as compared to their controls, pretreated with the same doses of the inhibitor and treated with vehicle (40.5% and 38.7%, respectively) and to those pretreated with vehicle and treated with the same toxin. The pretreatment with N(w)-nitro-L-arginine methyl to ester at low dose (1 mg/kg) resulted in a discrete inhibition of the gastric emptying delay induced by lipopolysaccharide. Nevertheless, N(w)-nitro-L-arginine methyl to ester at higher doses (2.5 and 5 mg/kg) induced an enhancement of the lipopolysaccharide effect on gastric emptying, despite not interfering with the gastric emptying per se.43229-3
Efeito do lipopolissacarídio bacteriano sobre o esvaziamento gástrico de ratos: avaliação do pré-tratamento com dexametasona e azul de metileno
RACIONAL: O óxido nítrico pode estar envolvido no retardo do esvaziamento gástrico produzido pelo lipopolissacarídio bacteriano. OBJETIVO: Avaliar o efeito do pré-tratamento com a dexametasona, bloqueadora da indução do óxido nítrico-sintetase induzida e com o azul de metileno, que bloqueia a guanilato-ciclase, inibe as óxido nítrico-sintetases e inativa o óxido nítrico, sobre o retardo do esvaziamento gástrico determinado pelo lipopolissacarídio em ratos. MATERIAL E MÉTODOS: Foram utilizados ratos Wistar, machos, ''specific patogen free'', após 24 horas de jejum alimentar. No pré-tratamento foram empregadas, via intravenosa, soluções de dexametasona (3 e 6 mg/kg), azul de metileno (2 mg/kg) e veículo estéril. O tratamento constou da administração, via intravenosa, de lipopolissacarídio (50 mig/kg) e veículo. O intervalo entre o pré-tratamento e o tratamento foi de 10 minutos, exceto no estudo com dexametasona 6 mg/kg, que foi de 1 hora. O intervalo entre a administração do lipopolissacarídio e a avaliação do esvaziamento gástrico foi de 1 hora, exceto nos dois estudos com dexametasona 3 mg/kg que foram de 2 e 8 horas. O esvaziamento gástrico foi avaliado, indiretamente, através da determinação da percentagem de retenção gástrica de solução salina marcada com fenol vermelho. RESULTADOS: Os valores de retenção gástrica, nos animais pré-tratados com dexametasona ou azul de metileno e tratados com veículo, não diferiram significativamente dos observados nos que receberam veículo nos dois momentos. Os animais pré-tratados com veículo e tratados com lipopolissacarídio apresentaram valores de retenção gástrica significativamente mais elevados que nos controles. O pré-tratamento com dexametasona não interferiu no aumento da retenção gástrica determinado pelo lipopolissacarídio, nas primeiras 2 horas após administração da endotoxina. Oito horas após a administração da endotoxina, foi observada diminuição significativa da retenção gástrica nos animais pré-tratados com dexametasona e tratados com lipopolissacarídio em relação aos que receberam veículo + lipopolissacarídio. O mesmo fenômeno foi observado nos animais pré-tratados com azul de metileno e tratados com lipopolissacarídio. CONCLUSÃO: Os resultados sugerem o envolvimento do óxido nítrico no efeito do lipopolissacarídio sobre o esvaziamento gástrico em ratos
The Ontogeny Of Saliva Secretion In Infants And Esophagoprotection.
Several studies have reported that severe reflux esophagitis is rare in infants despite the well known high occurrence of regurgitation in early infancy. There is evidence of the importance of saliva for the pre-epithelial protection of the esophageal mucosa. A longitudinal study conducted on healthy infants indicated that the stimulated capacity of saliva secretion (saliva output per kg of body weight) was significantly higher during their first year of age compared to older children and adults. In addition, this secretion pattern was also observed in low weight newborns during the first weeks of life and persisted in infants with severe protein-calorie malnutrition (marasmus). The greater ability to secrete saliva is an important physiological condition that may protect the infant from acid/pepsin aggression to the esophagus during early stages of development.52156-16